FDA Approved: VIGABATRIN FOR ORAL SOLUTION — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for Vigabatrin as an oral solution, adding a new formulation of the antiepileptic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN FOR ORAL SOLUTION (VIGABATRIN)